Novel xanthin derivatives, production and use thereof as medicaments

作者: Elke Langkopf , Mohammad Tadayyon , Matthias Eckhardt , Frank Himmelsbach , Michael Mark

DOI:

关键词:

摘要: The invention relates to substituted xanthins of general formula (I) wherein R1 - R4 are defined as in Claim 1, the tautomers thereof, stereoisomers mixtures prodrugs and salts thereof which exhibit valuable pharmacological properties, especially an inhibitive effect on activity enzyme Dipeptidylpeptidase-IV (DPP-IV).

参考文章(7)
Eita Emori, Fumiyoshi Matsuura, Nobuyuki Yasuda, Tadashi Nagakura, Hironori Ikuta, Seiji Yoshikawa, Clark Richard, Kazuto Yamazaki, Kazunobu Kira, Novel fused imidazole derivative ,(2003)
Peter G. M. Wuts, Theodora W. Greene, Protective groups in organic synthesis ,(1981)
Brent Blackburn, Alan G. Olivero, Kirk Robarge, Halo-alkoxycarbonyl prodrugs ,(1998)
Jane Marie Lundbeck, Anders Bendtz Kanstrup, Lise Brown Christiansen, Marit Kristiansen, Christian Klarner Sams, Dpp-iv-inhibiting purine derivatives for the treatment of diabetes ,(2002)
FrankHimmelsbach Frank Himmelsbach, RolandMaier Roland Maier, ElkeLangkopf Elke Langkopf, MathiasEckhardt Mathias Eckhardt, RalfLotz Ralf Lotz, MichaelMark Michael Mark, Xanthine derivative, production and use thereof as a medicament ,(2002)
Jane Marie Lundbeck, Anders Bendtz Kanstrup, Lise Brown Christiansen, Marit Kristiansen, Christian K Sams, Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv) ,(2001)
Samuel Chackalamannil, Yuguang Wang, Andrew W. Stamford, Craig D. Boyle, Xanthine phosphodiesterase v inhibitors ,(2001)